Keymed Biosciences Inc. announced a transaction involving the placing of existing shares and a top-up subscription of new shares. The transaction was coordinated by the Lead Bookrunner and Joint Bookrunners, who acted as agents for the Top-up Vendor. The shares were intended for professional, institutional, corporate, or other investors. Specific details regarding the total number of shares and the price were not provided in the document.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.